| EPIC | CREO |
| Sector | Health Care |
| ISIN | GB00BZ1BLL44 |
| Market Sector | AIM |
| Market Segment | ASQ1 |
| Main Indices | FTSE AIM All-Share |
| Country of register | Great Britain |
| Currency | British Pound |
| Market Cap | £46.61m |
| NMS | 1,500 |
| Shares in issue | 412.47m |
| Date Listed | n/a |
| Currency | UK Pounds |
| Share Price | 11.30p |
| Change Today | 0.050p |
| % Change | 0.44 % |
| 52 Week High | 20.00 |
| 52 Week Low | 9.55 |
| Volume | 371,977 |
| Shares Issued | 412.47m |
| Market Cap | £46.61m |
| Beta | 0.52 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| Strong Buy | 1 |
| Buy | 0 |
| Neutral | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 1 |

| No dividends found |
| Time | Volume / Share Price |
| 14:15 | 150,000 @ 11.27p |
| 13:45 | 100,000 @ 11.27p |
| 13:04 | 26,535 @ 11.27p |
| 12:54 | 1 @ 11.27p |
| 12:45 | 400 @ 11.27p |
| CEO | Craig Jonathan Gulliford |
| CFO | Richard John Rees |
| Chair | Kevin Crofton |
You are here: research